Skip to main content

Advertisement

SpringerLink
Log in

The use of desmopressin in congenital factor XI deficiency: a systematic review

  • Review Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Factor XI (FXI) deficiency is a rare inherited coagulation disorder characterized by infrequent spontaneous bleeding, but increased risk of hemorrhagic complications especially after trauma or surgery. Treatment options for FXI-deficient patients include virus-inactivated fresh frozen plasma, plasma-derived FXI concentrates, and activated recombinant FVII. Inhibitors of fibrinolysis, such as tranexamic acid, and desmopressin (DDAVP) have also been used in these patients, especially in mild cases. The current knowledge on the use of the latter agent in this congenital bleeding condition is systematically reviewed here. Although limited, the available literature data suggest the potential role of DDAVP for either treatment of bleeding episodes or the prevention of postoperative bleeding in patients with milder FXI defects. However, these findings need to be supported by further trials on large population of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Smith JK (1996) Factor XI deficiency and its management. Haemophilia 2:128–136

    Google Scholar 

  2. Bolton-Maggs PHB (1995) Factor XI deficiency: a review. Haemophilia 1:217–221

    Article  Google Scholar 

  3. Bolton-Maggs PHB, Perry DJ, Chalmers EA, Parapia LA, Wilde JT, Williams MD, Collins PW, Kitchen S, Dolan G, Mumford AD (2004) The rare coagulation disorders—review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 10:593–628

    Article  PubMed  CAS  Google Scholar 

  4. Salomon O, Seligsohn U (2004) New observations on factor XI deficiency. Haemophilia 10(Suppl. 4):184–187

    Article  PubMed  Google Scholar 

  5. Franchini M, Veneri D, Lippi G (2006) Inherited factor XI deficiency: a concise review. Hematology 11:307–309

    Article  PubMed  CAS  Google Scholar 

  6. O’Connell NM (2003) Factor XI deficiency—from molecular genetics to clinical management. Blood Coagul Fibrinolysis 14(Suppl. 1):S59–S64

    Article  PubMed  Google Scholar 

  7. Bolton-Maggs PHB (1998) The management of factor XI deficiency. Haemophilia 4:683–688

    Article  PubMed  CAS  Google Scholar 

  8. Bolton-Maggs PH, Colvin BT, Satchi BT, Lee CA, Lucas GS (1994) Thrombogenic potential of factor XI concentrate. Lancet 344:748–749

    Article  PubMed  CAS  Google Scholar 

  9. Mannucci PM, Bauer KA, Santagostino E, Faioni E, Barzegar S, Coppola R, Rosenberg RD (1994) Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients. Blood 84:1314–1319

    PubMed  CAS  Google Scholar 

  10. O’Connell NM (2004) Factor XI deficiency. Semin Hematol 41(Suppl 1):76–81

    Article  PubMed  Google Scholar 

  11. Lawler P, White B, Pye S, Hermans C, Riddell A, Costello C, Brown S, Lee CA (2002) Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency. Haemophilia 8:145–148

    Article  PubMed  CAS  Google Scholar 

  12. Bern MM, Sahud M, Zhukov O, Qu K, Mitchell W Jr (2005) Treatment of factor XI inhibitor using recombinant activated factor VIIa. Haemophilia 11:20–25

    Article  PubMed  CAS  Google Scholar 

  13. Schulman S, Nemeth G (2006) An illustrative case and a review on the dosing of recombinant facto VIIa in congenital factor XI deficiency. Haemophilia 12:223–227

    Article  PubMed  CAS  Google Scholar 

  14. Berliner S, Horowitz I, Martinowitz U, Brenner B, Seligsohn U (1992) Dental surgery in patients with severe factor XI deficiency without plasma replacement. Blood Coagul Fibrinolysis 3:465–468

    Article  PubMed  CAS  Google Scholar 

  15. Kadir RA, Economides DL, Lee CA (1999) Factor XI deficiency in women. Am J Hematol 60:48–54

    Article  PubMed  CAS  Google Scholar 

  16. Rodeghiero F (2008) Management of menorrhagia in women with inherited bleeding disorders: general principles and use of desmopressin. Haemphilia 14(Suppl. 1):21–30

    CAS  Google Scholar 

  17. Cattaneo M (1997) Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disorders. Eur J Anaesthesiol 14(Suppl. 14):10–18

    Article  CAS  Google Scholar 

  18. Franchini M (2007) The use of desmopressin as a hemostatic agent: a concise review. Am J Hematol 82:731–735

    Article  PubMed  CAS  Google Scholar 

  19. Crescenzi G, Landoni G, Biondi-Zoccai G, Pappalardo F, Nuzzi M, Bignami E, Fochi O, Maj G, Calabrò MG, Ranucci M, Zangrillo A (2008) Desmopressin reduces transfusion needs after surgery. Anesthesiology 109:1063–1076

    Article  PubMed  CAS  Google Scholar 

  20. Angelis De, Orazi BM, Santarossa L, Molaro G (1990) Combined factor VIII and factor XI congenital deficiency: a case report. Haematologica 75:272–273

    PubMed  Google Scholar 

  21. Castaman G, Ruggeri M, Rodeghiero F (1996) Clinical usefulness of desmopressin for prevention of surgical bleeding in patients with symptomatic heterozygous factor XI deficiency. Br J Hematol 94:168–170

    Article  CAS  Google Scholar 

  22. Bauduer F, Bendriss P, Freyburger G, Ducout L, Marti B (1998) Use of desmopressin for prophylaxis of surgical bleeding in factor XI-deficient patients. Acta Haematol 99:52–53

    Article  PubMed  CAS  Google Scholar 

  23. Franchini M, de Gironcoli M, Lippi G, Manzato F, Aprili G, Gandini G (2000) Prophylactic use of desmopressin in surgery of six patients with symptomatic heterozygous factor XI deficiency. Haematologica 85:106–107

    PubMed  CAS  Google Scholar 

  24. Garcia Fernandez JR, Sánchez Forte M, Diego Fernández P, López Berenguel F, Moreno Madrid F (2002) Familial study of factor XI deficiency. Presurgical prophylactic treatment with desmopressin plus antifibrinolytics. An Esp Pediatr 57:373–377

    PubMed  CAS  Google Scholar 

  25. Heim MU, Lutze G, Aumann V, Schumacher J, Freigang B (2002) Postoperative haemorrhagia in a girl with congenital factor XI deficiency—successful treatment with desmopressin (DDAVP, Minirin). Klin Padiatr 214:128–131

    Article  PubMed  CAS  Google Scholar 

  26. Ruiz-Saez A, Arguello A, Boadas A, Feijoo R, Bosch N (2003) Factor XI deficiency in Mestizo Venezuelan population. J Thromb Haemost 1(Suppl. 1):P1205 abstract

    Google Scholar 

  27. Franchini M, Zugni C, Veneri D, Gandini G, Lippi G, Manzato F, Brazzarola P (2004) High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery. Haematologica 89:1341–1346

    PubMed  Google Scholar 

  28. Agnelli G, Parise P, Levi M, Cosmi B, Nenci GG (1995) Effects of desmopressin on hemostasis in patients with liver cirrhosis. Haemostasis 25:241–247

    PubMed  CAS  Google Scholar 

  29. White B, Lawler P, Riddell A, Nitu-Whalley IC, Hermans C, Lee CA, Brown SA (2004) Response to desmopressin of factors XI, X and V in patients with factor VIII deficiency and von Willebrand disease. Br J Haematol 126:100–104

    Article  PubMed  CAS  Google Scholar 

  30. Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL (2002) DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study. Haemophilia 8:787–793

    Article  PubMed  CAS  Google Scholar 

  31. Mannucci PM (1998) Hemostatic agents. N Engl J Med 339:245–253

    Article  PubMed  CAS  Google Scholar 

  32. Salomon O, Steinberg DM, Tamarin I, Zivelin A, Seligsohn U (2005) Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency. Blood Coagul Fibrinolysis 16:37–41

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servizio di Immunoematologia e Medicina Trasfusionale, Dipartimento di Patologia e Medicina di Laboratorio, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy

    Massimo Franchini

  2. Laboratorio di Patologia Clinica, Ospedale “Carlo Poma”, Mantova, Italy

    Franco Manzato

  3. Sezione di Chimica Clinica, Dipartimento di Scienze Biomediche e Morfologiche, Università di Verona, Verona, Italy

    Gian Luca Salvagno, Martina Montagnana & Giuseppe Lippi

Authors
  1. Massimo Franchini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Franco Manzato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gian Luca Salvagno
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Martina Montagnana
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giuseppe Lippi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Massimo Franchini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Franchini, M., Manzato, F., Salvagno, G.L. et al. The use of desmopressin in congenital factor XI deficiency: a systematic review. Ann Hematol 88, 931–935 (2009). https://doi.org/10.1007/s00277-009-0792-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-009-0792-9

Keywords

Search

Navigation